BCYC
Price
$8.10
Change
+$0.25 (+3.18%)
Updated
Apr 2, 02:43 PM (EDT)
Capitalization
543.24M
29 days until earnings call
FHTX
Price
$3.38
Change
-$0.27 (-7.40%)
Updated
Apr 1 closing price
Capitalization
187.69M
40 days until earnings call
Ad is loading...

BCYC vs FHTX

Header iconBCYC vs FHTX Comparison
Open Charts BCYC vs FHTXBanner chart's image
Bicycle Therapeutics
Price$8.10
Change+$0.25 (+3.18%)
Volume$100
Capitalization543.24M
Foghorn Therapeutics
Price$3.38
Change-$0.27 (-7.40%)
Volume$135.41K
Capitalization187.69M
BCYC vs FHTX Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. FHTX commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and FHTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (BCYC: $7.85 vs. FHTX: $3.38)
Brand notoriety: BCYC and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 134% vs. FHTX: 99%
Market capitalization -- BCYC: $543.24M vs. FHTX: $187.69M
BCYC [@Biotechnology] is valued at $543.24M. FHTX’s [@Biotechnology] market capitalization is $187.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while FHTX’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 3 bearish.
  • FHTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than FHTX.

Price Growth

BCYC (@Biotechnology) experienced а -11.30% price change this week, while FHTX (@Biotechnology) price change was -14.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.99%. For the same industry, the average monthly price growth was -7.23%, and the average quarterly price growth was -11.71%.

Reported Earning Dates

BCYC is expected to report earnings on May 01, 2025.

FHTX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-4.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($543M) has a higher market cap than FHTX($188M). FHTX YTD gains are higher at: -28.496 vs. BCYC (-43.929). FHTX has higher annual earnings (EBITDA): -97.17M vs. BCYC (-164.89M). BCYC has more cash in the bank: 880M vs. FHTX (244M). BCYC has less debt than FHTX: BCYC (9.49M) vs FHTX (37.1M). BCYC has higher revenues than FHTX: BCYC (35.3M) vs FHTX (22.6M).
BCYCFHTXBCYC / FHTX
Capitalization543M188M289%
EBITDA-164.89M-97.17M170%
Gain YTD-43.929-28.496154%
P/E RatioN/AN/A-
Revenue35.3M22.6M156%
Total Cash880M244M361%
Total Debt9.49M37.1M26%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCFHTX
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 6 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 22 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTCLX64.650.68
+1.06%
MFS Technology R6
HDQVX16.250.06
+0.37%
Janus Henderson Responsible Intl DivS
PIPTX16.12N/A
N/A
Virtus KAR Global Quality Dividend I
CMGIX37.52N/A
N/A
BlackRock Mid-Cap Growth Equity Instl
NMCCX5.84N/A
N/A
Voya MidCap Opportunities C

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with ABOS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-7.53%
ABOS - FHTX
52%
Loosely correlated
-2.27%
NAUT - FHTX
50%
Loosely correlated
-3.59%
AVIR - FHTX
48%
Loosely correlated
-4.68%
XNCR - FHTX
47%
Loosely correlated
-8.93%
DNLI - FHTX
46%
Loosely correlated
-9.60%
More